Literature DB >> 2611769

Quantification of cerebrospinal fluid shunt flow rates. Assessment of the programmable pressure valve.

M Matsumae1, O Sato, K Itoh, T Fukuda, Y Suzuki.   

Abstract

Shunt placement diverting cerebrospinal fluid (CSF) has been the treatment of choice for hydrocephalus for the past several decades. However, the procedure often requires revisions owing to excessive drainage, low CSF flow rates, or infections within the system. With regard to valve pressure, selection of an appropriate valve for a specific patient prior to surgery is not always a simple task. Further, an optimal valve selected at the time of implantation may no longer be appropriate given changing pathophysiological conditions as time passes. It is thus desirable to provide a single valve in which the pressure may be modified when necessary without revision. A programmable pressure valve (designed by Sophysa of France) comes in one model which accommodates different pressure settings obviating revision when pressure changes are needed. Pressure changes can be achieved externally by means of a special magnet which allows precise adjustments in valve pressure to be made through the scalp. The authors introduce the mechanism and describe the cases treated using this valve.

Entities:  

Mesh:

Year:  1989        PMID: 2611769     DOI: 10.1007/bf00271892

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  6 in total

1.  Cerebrospinal fluid shunts: an experimental evaluation of flow rates and pressure values in the anti-siphon valve.

Authors:  J L Fox; H D Portnoy; R R Shulte
Journal:  Surg Neurol       Date:  1973-09

2.  Isolated unilateral hydrocephalus following ventriculoatrial shunt.

Authors:  J H Salmon
Journal:  J Neurosurg       Date:  1970-02       Impact factor: 5.115

3.  Cerebrospinal fluid shunts: an experimental comparison of flow rates and pressure values in various commercial systems.

Authors:  J L Fox; D C McCullough; R C Green
Journal:  J Neurosurg       Date:  1972-12       Impact factor: 5.115

4.  Dynamic changes of cerebrospinal fluid shunt flow in patient's daily life.

Authors:  M Matsumae; T Murakami; M Ueda; Y Suzuki; O Sato
Journal:  Childs Nerv Syst       Date:  1987       Impact factor: 1.475

5.  Isolated fourth ventricle as a complication of ventricular shunting. Report of three cases.

Authors:  J C Hawkins; H J Hoffman; R P Humphreys
Journal:  J Neurosurg       Date:  1978-12       Impact factor: 5.115

6.  Slit ventricles as a cause of isolated ventricles after shunting.

Authors:  S Oi; S Matsumoto
Journal:  Childs Nerv Syst       Date:  1985       Impact factor: 1.475

  6 in total
  5 in total

1.  Safety of the adjustable pressure ventricular valve in magnetic resonance imaging: problems and solutions.

Authors:  P Fransen; G Dooms; C Thauvoy
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

2.  Overdrainage and shunt technology. A critical comparison of programmable, hydrostatic and variable-resistance valves and flow-reducing devices.

Authors:  A Aschoff; P Kremer; C Benesch; K Fruh; A Klank; S Kunze
Journal:  Childs Nerv Syst       Date:  1995-04       Impact factor: 1.475

Review 3.  Novel approaches to treating leptomeningeal metastases.

Authors:  Jai Grewal; Marlon Garzo Saria; Santosh Kesari
Journal:  J Neurooncol       Date:  2011-08-28       Impact factor: 4.130

4.  Adjustable vs set-pressure valves decrease the risk of proximal shunt obstruction in the treatment of pediatric hydrocephalus.

Authors:  Matthew J McGirt; Donald W Buck; Daniel Sciubba; Graeme F Woodworth; Benjamin Carson; Jon Weingart; George Jallo
Journal:  Childs Nerv Syst       Date:  2006-11-15       Impact factor: 1.475

5.  Intracranial pressure monitoring using a programmable pressure valve and a telemetric intracranial pressure sensor in a case of slit ventricle syndrome after multiple shunt revisions.

Authors:  T Kamiryo; Y Fujii; M Kusaka; S Kashiwagi; H Ito
Journal:  Childs Nerv Syst       Date:  1991-08       Impact factor: 1.475

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.